ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence. [electronic resource]
Producer: 20190415Description: 1695-1701 p. digitalISSN:- 1534-6080
- ABO Blood-Group System -- immunology
- Adult
- Aged
- Allografts -- immunology
- Blood Group Incompatibility -- immunology
- Carcinoma, Hepatocellular -- epidemiology
- Disease-Free Survival
- End Stage Liver Disease -- surgery
- Female
- Graft Rejection -- immunology
- Humans
- Isoantibodies -- immunology
- Liver -- immunology
- Liver Neoplasms -- epidemiology
- Liver Transplantation -- adverse effects
- Living Donors
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- epidemiology
- Plasma Exchange -- adverse effects
- Preoperative Care -- adverse effects
- Rituximab -- adverse effects
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.